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Abstract
Background: Genome editing is transforming bioscience research, but its application to non-model organisms,
such as farmed animal species, requires optimisation. Salmonids are the most important aquaculture species by
value, and improving genetic resistance to infectious disease is a major goal. However, use of genome editing to
evaluate putative disease resistance genes in cell lines, and the use of genome-wide CRISPR screens is currently
limited by a lack of available tools and techniques.
Results: In the current study, we developed an optimised protocol using lentivirus transduction for efficient
integration of constructs into the genome of a Chinook salmon (Oncorhynchus tshwaytcha) cell line (CHSE-214). As
proof-of-principle, two target genes were edited with high efficiency in an EGFP-Cas9 stable CHSE cell line;
specifically, the exogenous, integrated EGFP and the endogenous RIG-I locus. Finally, the effective use of antibiotic
selection to enrich the successfully edited targeted population was demonstrated.
Conclusions: The optimised lentiviral-mediated CRISPR method reported here increases possibilities for efficient
genome editing in salmonid cells, in particular for future applications of genome-wide CRISPR screens for disease
resistance.
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Background
Aquaculture is the fastest growing food production sec-
tor, and has overtaken capture fisheries as the primary
source of seafood for human consumption [1]. However,
farmed production of finfish, shellfish, and crustacean
species all suffer from infectious diseases that can have
negative impacts on animal welfare, the environment,
and on commercial viability, constraining future expan-
sion. Selective breeding for improved disease resistance
is a promising avenue to tackle these diseases, and has
been widely practiced for Atlantic salmon (Salmo salar)
and other salmonid species [2, 3]. Family-based selection
based on siblings trait recording is now typically aug-
mented with the use of molecular genetic markers, ei-
ther via marker-assisted selection (based on markers
linked to quantitative trait loci, QTL) or genomic selec-
tion using genome-wide markers to predict breeding
values [4]. However, to date, little is yet known about
the functional genes and variants underlying this genetic
resistance to disease.
Genome editing using reprogrammed CRISPR/Cas9
systems has emerged as a revolutionary tool to make
specific and targeted changes to genomes of species’ of
interest. CRISPR/Cas9 can facilitate identification and
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characterisation of specific functional variants under-
lying QTL affecting the trait of interest. The technology
facilitates precise gene knockout, activation or inhibition,
and can also allow targeted deletion, insertion and even
epigenetic modification of genomic DNA [5]. As such,
CRISPR/Cas9 can be applied to test targeted perturb-
ation of candidate genes and variants within QTL
regions, to assess the consequence on the trait of inter-
est. This knowledge raises the possibility of enhancing
genomic selection accuracy via increased weighting on
functional variants. In addition, genome editing can
potentially by applied to create de novo variation, or to
introduce favourable alleles segregating in closely related
strains or species [6].
The aforementioned genome editing approaches typic-
ally focus on a single target locus, and there are several
examples of successful CRISPR editing of single loci
in vivo in farmed fish species (e.g. [7, 8]), reviewed in
[6]). CRISPR/Cas9 has also been successfully applied in
salmonid cell culture models to investigate specific com-
ponents of the interferon pathway [9]. Another exciting
application that has emerged in recent years is the devel-
opment of genome-wide CRISPR knock out screens in
cell culture models [10]. This involves creating a library
of tens/hundreds of thousands of guide RNAs (gRNA)
targeting either every gene in the genome of the species
of interest, or targeting non-translated regions such as
enhancers or miRNA [11]. These guides are then synthe-
sised, packaged into a lentivirus vector, and transduced
into a cell line constitutively expressing Cas9 (or alterna-
tively the transduced construct can also code for the
Cas9 protein). The lentivirus dose used results in ap-
proximately one gRNA integration per cell. The cell pool
is then screened (e.g. using a pathogen challenge) and
the selected cells (surviving, fluorescently labelled, or an-
other marker of selection) sequenced. The enrichment
or depletion of gRNAs compared to the control popula-
tion informs on the role of their target genes in the
phenotype under investigation. This approach has led to
fundamental host-pathogen discoveries, particularly in
virology as the cell intrinsic nature of the innate immune
response is very well suited to interrogation with this
platform. Such screens have led to the discovery of the
Norovirus receptor [12] and the role of endoplasmic
reticulum membrane complex in Zika virus infection
[13]. Genome-wide screens have been applied in several
species, from humans to fly [14], including parasites
such as Toxoplasma gondii [15], and plants [16] but has
yet to be applied in farmed fish species, where it could
have major potential for discovering genes involved in
disease resistance, and improving knowledge of host-
pathogen interaction.
There are currently several barriers and knowledge
gaps preventing the application of genome-wide screens
in fish. However, one major barrier was overcome when
a potentially suitable cell line was created by Dehler
et al. [17], using a random plasmid integration event to
stably express Cas9 in the Chinook salmon (Oncorhyn-
chus tshawytscha) cell line (CHSE-EC), a cell line fre-
quently used to study viral diseases of interest to farmed
salmonid production. Further, this transgenic line was
also modified to stably express EGFP, and Dehler et al.
used electroporation of gRNA to successfully knockout
the integrated EGFP locus, reporting approximately 35%
successful editing. Using this approach, they developed
clonal lines of CHSE STAT2 KO and explored the role
of this gene in antiviral immunity [9]. Alternatively, the
genome editing cargo can be delivered by transient
transfection of a plasmid expressing Cas9 and gRNA.
Escobar et al., [18] successfully edited the genome in the
CHSE cell line but reported a low transfection/expres-
sion efficiency (10%) and did not report editing effi-
ciency. To harness the CHSE-EC (or similar Cas9 stable)
cell lines as a platform for high-throughput screens, an
efficient lentivirus delivery system for the genome-wide
library would be highly desirable.
Lentiviral transduction of Cas9 and gRNA has several
advantages over other methods, such as electroporation
of ribonucleoprotein or transient plasmid transfection. It
efficiently integrates into the genome, enabling the cre-
ation of stable cell lines, and allows for the integration of
antibiotic resistance markers and fluorescent reporters
to perform enrichment of edited cells. A multitude of
lentivirus plasmid constructs already exist, and have
been successfully tested in various species. For these rea-
sons, lentivirus is the delivery method of choice for
genome-wide libraries, but has not yet been developed
in fish cell lines. In the current study, an efficient
lentivirus-based method for genome editing in a sal-
monid fish cell line is presented. The delivery of lenti-
virus was optimised to allow integration of a transgene
at high efficiency. Using a lentivirus delivered gRNA in
the salmonid cell line CHSE-EC, a very high efficiency of
genome editing was obtained, after antibiotic enrichment
of cells containing both Cas9 and specific gRNA. Finally,
as proof of principle, the method was applied to estab-
lish a polyclonal cell line enriched for retinoic acid-
inducible gene-I-like (RIG-I) knock-out cells.
Results
Efficient transduction of Chinook salmon cells with
lentivirus
To improve CRISPR/Cas9 delivery and genome editing
efficiency, lentiviral transduction was optimised for use
in salmonid cell lines. This was initially performed using
a fluorescent reporter construct (CMV:EGFP) in the
Chinook salmon cell line (CHSE-214, referred to here-
after as CHSE). To optimise the transduction efficiency,
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three major variables were tested [19, 20]; specifically (i)
the impact of incubation temperature; (ii) the impact of
including a spinfection (or spinoculation); and (iii) the
impact of the duration of the incubation. Flow cytometry
was used to determine the efficiency of transduction by
measuring the number of fluorescent cells (therefore
assumed to be transduced with the CMV-EGFP), with
the outputs from the optimised settings shown in Fig. 1a
and b.
Temperature of incubation had a major impact on trans-
duction efficiency, with an increased transduction efficiency
from 1 to 63% as the temperature was increased from 17 °C
to 22 °C (Fig. 1c). Further increase in temperature to 28 °C
for 4 h (heat shock) followed by 22 °C incubation (denoted
28–22) resulted in a minor increase in transduction effi-
ciency, from 63 to 73% (Fig. 1c), but overnight incubation
at 28 °C caused mortality in the CHSE cells (data not
shown). Using the settings of 22 °C incubation for 24 h and
neat supernatant of lentivirus, we included a spinfection
step and show an improvement of transduction efficiency
from 47 to 63% (Fig. 1c). Finally, reducing the incubation
time of the cells with the lentivirus from 24 h to 4 h
reduced the transduction efficiency from 63 to 43% for
22 °C incubation and 73 to 53% for 28–22 incubation group
(Fig. 1d). Therefore, we propose an optimised protocol for
efficient transduction of CHSE cells using neat lentivirus
supernatant on suspended cells, together with a spin-
fection step (2 h at 1000 x g) and incubation for 24 h
at 22 °C (Fig. 1a, b). These optimised settings were
used for downstream experiments.
Efficient editing of the Chinook salmon genome using a
lentivirus system
After optimising the transduction conditions by integrat-
ing a GFP expressing construct into the CHSE cell line,
a modified CHSE cell line stably expressing Cas9 and
EGFP (CHSE-EC [17]) was used to test Cas9-mediated
genome editing in these cells. A plasmid, containing a
human U6 promoter to drive the expression of a
second-generation gRNA scaffold and the puromycin
antibiotic resistance gene was used [21]. The use of the
human U6 promoter to drive the expression of a gRNA
Fig. 1 CHSE salmon cells are efficiently transduced with lentivirus. a Efficient transduction of CMV:EGFP in CHSE Chinook salmon cell line by
lentivirus. Salmon cells were spinfected at 22 °C with neat lentivirus supernatant for 2 h at 1000 x g. The cells were incubated for 24 h and the
media was replaced. After 2 weeks of expansions, fluorescence was recorded by flow cytometry using CHSE wt (not transduced) as control. Split
histogram of control cells (top) and pLenti-GFP transduced CHSE with optimal conditions (bottom). Data were normalised to Mode (relative
percentage of cells rather than number). b Representative image of CHSE cells 8 days post transduction with pLenti-GFP. Differential Interference
Contrast (top) and GFP (bottom) channels are represented. Arrows point to GFP negative cells. Scale bar 20 μm. c-d Different conditions of the
optimisation protocol with optimal conditions in purple. c, Incubation temperature and spinfection influences the efficiency of transduction. Cells
were transduced with neat lentivirus supernatant, spinfected for 2 h at 1000 x g (or not) and incubated at 17 °C (17), 22 °C (22) or heat shocked
for 4 h at 28 °C followed by 22 °C for 2 weeks (28–22) until flow cytometry. d, Incubation of the cells with the virus for 4 h reduces the efficiency
of transduction. CHSE were transduced with neat lentivirus dose at different temperatures and media was changed after 4 or 24 h
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has previously been reported to be inefficient in this
salmonid cell line [18]. Therefore, to first test this, the
gRNA sequence for EGFP [22] was cloned in this plas-
mid (pKLV2_EGFP), and transduced CHSE-EC cells
using the optimised protocol described previously. Edit-
ing efficiency was determined by loss of fluorescence for
EGFP editing as well as sequencing of pooled popula-
tions of cells (EGFP and RIG-I targets) followed by
deconvolution of the pooled sequencing chromatogram
using the ICE online software (Synthego Inc., example in
Additional file 2: FigS2).
Neat lentivirus supernatant was used to transduce
CHSE-EC, which resulted in up to 89.9% reduction in
fluorescent cells by flow cytometry (Fig. 2a, b). A 10-fold
dilution of the lentivirus supernatant was also used to
validate the antibiotics enrichment. This yielded a 42.9%
loss of fluorescence, which could be effectively enriched
using puromycin selection for 1 week (Additional file 1:
Fig. S1), to 82.5% loss (Lo + Puro, Fig. 2b, c). In close
agreement with the flow cytometry data, Sanger sequen-
cing analysis of the target region showed 70% editing
(cutting efficiency using ICE, Synthego Inc) of the cells
in the neat supernatant group (and 58% in the low dose
enriched, Fig. 2c). Deconvolution of the chromatogram
edit patterns (ICE analysis) shows that the majority of
the edited sequences had a 1 bp insertion (27%) and only
15% of the sequences were estimated to be unedited
(Fig. 2d).
In summary, the results show that the pKLV2 plasmid
(containing the human U6 promoter) is functional and
effective at transcribing gRNA in the CHSE cell line, and
that the lentivirus delivery strategy (either neat, or di-
luted together with antibiotic selection for enrichment)
leads to very high genome editing efficiency.
To validate that the editing strategy was efficient on a
salmon gene, the Chinook salmon retinoic acid-
inducible gene-I-like (RIG-I) locus (DDX58, NCBI Gene
LOC112222314) was targeted, by creating a pKLV2_
RIG-I construct. This gene was chosen as it is central in
the antiviral defense against RNA virus [23], it exists as a
single copy in the chinook salmon genome, and because
knockout cell lines may be useful models for future
studies of host response to these viruses. The CHSE-EC
cells were transduced with pKLV2_RIG-I supernatant,
followed by puromycin selection for 7 days. At least 47%
of the cells were edited at the desired locus (Puro-, Fig.
2e) and this was enriched to 60% using puromycin selec-
tion (Puro+, Fig. 2e). Similarly to the EGFP edited cells
(Fig. 2d), 1 bp insertion was the most common type of
edit detected (Fig. 2f). We also sequenced the 2 top off-
targets regions predicted by CRISPOR (TableS1) and
evaluated editing using Sanger sequencing as previously
described (FigS2). No editing was detected in either of
the regions (FigS3). These results demonstrate that
endogenous genes in the chinook salmon CHSE cell line
can be targeted for genome editing using lentivirus.
Taken together, these results show that the lenti-
virus delivery strategy described herein, together with
the Cas9 expressing CHSE cell line (CHSE-EC) can
easily, rapidly and efficiently be used to edit the
genome of salmonid cells, and suggests that the
method could be applied to the new generation of
CRISPR/Cas9 platforms such as base editors and
CRISPR activation/inhibition.
Discussion
The results of the current study show efficient lentivirus
transduction in the salmonid cell line CHSE-214 and the
first demonstration of lentivirus-mediated editing in sal-
monid fish cells. The optimised protocol described re-
sults in the most efficient genome editing of a salmonid
cell line to date. However, it is important to note that
the results are based on single experimental replicates,
and it will be beneficial to repeat the editing in this cell
line, as well as to test in other fish cell lines to demon-
strate the versatility of the method. Nonetheless, this
study paves the way to high-throughput genome editing
in salmonid cells, and for simpler generation of trans-
genic cell lines.
Retroviruses have widely been used to infect animal
cells and to deliver cargo which can be integrated or
not in the genome [24]. Over 25 years ago, it was
shown that fish cells (zebrafish, Danio rerio ZF4, Rain-
bow trout, Oncorhynchus mykiss RTG-2 and Chinook
salmon, CHSE-214) could be transduced with retro-
virus (Moloney murine leukemia virus, MLV) after
subtyping it with the VSV-G envelope glycoprotein
(from Vesicular Stomatitis Virus) [25]. Thereafter, sev-
eral viral delivery vectors have been tested for the ex-
pression of genes (integrative or non-integrative
system) in several fish cells and in vivo, including
MLV [26], Semliki Forest Virus (SFV) [20], lentivirus,
adeno-virus (Ad) and adeno-associated virus (AAV)
[27–29], with levels of efficiency varying from very
high [Ad in zebrafish cells [27]] to low [MLV in me-
daka stem cells [26]]. Therefore, the transduction of
cell lines has been shown to be efficient with the
retrovirus system, but its adoption to edit the genome
of fish cell lines has not been demonstrated.
In the present study, the delivery method of the
retrovirus-derived second-generation lentivirus system
[30] was optimised to stably integrate an EGFP con-
struct in the salmonid cell line CHSE-214. Transduc-
tion efficiency is dependent on temperature and is
almost completely blocked at incubation below 17 °C.
The cell type and temperature influence on lentivirus
transduction efficiency has been reported previously
in mammalian cells [19, 31]. In fish cell lines, SFV
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infection was reduced 1000-fold in the Atlantic sal-
mon F95/9 cell line and completely blocked in CHSE-
214 as the temperature was decreased from 25 to
15 °C [20]. This temperature restriction is fortunately
not a limiting issue as most fish cell lines, derived from
cold or warm water species, are adapted to tempera-
tures of 20 °C or above [32]. Similar to several studies
in mammalian cells, adding a spinfection step (1000 x g
for 1–2 h) greatly enhanced the transduction efficiency
of LV in the current study [19, 33]. The relative ease of
stably integrating a reporter construct and possibly tag-
ging the native protein [34] is likely to help with
in vitro research in salmonid cell lines.
A major advantage of lentivirus transduction is the
possibility to integrate an antibiotic resistance cassette to
enrich the transduced cells. Using this approach, it is
possible to use a relatively low viral dose, which ensures
that a single copy of the insert is integrated in the gen-
ome, and subsequently enrich the transduced cells with
antibiotic treatment to very high proportion of cells. The
high transduction efficiency and genome editing
achieved offer advantages over less efficient gene editing
methods such as the possibility to directly use the cells
generated as a pooled population without the tenuous
process of single cell cloning. However, it should be
noted that lentivirus, like most integrating retroviruses,
Fig. 2 The genome of CHSE-EC salmon cells is efficiently edited with lentivirus. a-d Efficient editing of EGFP in CHSE-EC Chinook salmon cell line
by lentivirus. CHSE-EC cells were spinfected for 2 h at 1000 g with neat (Hi) and 1:10 dilution (Lo) of lentivirus supernatant and incubated at 22 °C.
After 2 weeks of expansion, puromycin was added to the Lo group (0.25 μg / mL, for 1 week, Lo + Puro). Fluorescence was imaged by
epifluorescence microscopy (a) and recorded flow cytometry (b) using CHSE wt and CHSE-EC (not transduced) as controls. Split histogram of
fluorescence and corresponding proportion histogram of control cells (top and bottom) and CHES-EC transduced with high and low
concentration (with and without puromycin treatment) lentivirus supernatant. Scale bar in a represents 20 μm. c Genome editing efficiency in
CHSE-EC by Sanger sequencing of PCR amplified product of the target loci, estimated by ICE analysis. d Detail of indels frequency in EGFP edited
Hi group (from panel c), estimated by ICE analysis. Purple dot denotes the unedited sequence (0 bp). e-f Efficient editing of RIG-I in CHSE-EC. e
Genome editing of the RIG-I gene in CHSE-EC. CHSE-EC cells were transduced similar to EGFP targeting (Puro-) and selected with puromycin
(Puro+) and efficiency estimated by ICE analysis of Sanger sequencing chromatogram from the PCR amplified target region. f Detail of indels
frequency in RIG-I edited Puro- group (from panel e), estimated by ICE analysis. Purple dot denotes the unedited sequence (0 bp)
Gratacap et al. BMC Biotechnology           (2020) 20:35 Page 5 of 9
tend to integrate at the site of active transcription (active
genes) and that an immune response (interferon stimu-
lated genes) has been reported with lentivirus transduc-
tion (i.e. infection) [35, 36].
By using the CHSE-EC cell line which constitutively
expressed Cas9, in combination with a lentivirus pack-
aging a gRNA construct targeting EGFP or RIG-I, the
genome of the salmonid cells was edited at very high
efficiency. Using this strategy, the previously reported
editing efficiency of 35% by electroporation of the gRNA
[17] was improved to almost 90% editing of EGFP (as
assessed by flow cytometry). Nonetheless, it should be
noted that electroporation of difficult-to-transduce cells
has been extremely successful and is also one of the
main approaches to edit the genome of mammalian
immune cells [37].
The expected positive correlation was observed
between the editing efficiency estimated by Sanger
sequencing and the phenotype observed when targeting
the exogenous EGFP gene in the CHSE-EC salmonid cell
line. However, disrupting specific pathways by precise
targeting of endogenous genes might be more challen-
ging, due to the recent salmonid whole genome duplica-
tion (approx. 95 million years ago, [38]). As such, it will
be necessary in many cases to target all paralogs to
achieve the desired phenotype. Moreover, several mech-
anisms have been hypothesized to explain genetic
robustness (i.e. a mutation not exhibiting the expected
phenotype), such as functional redundancy [39], rewiring
of genetic networks [40], adaptive mutations [41] or
transcriptional adaptation [42]. Finally, off-target are an
ever-present concern when editing the genome with
Cas9 and great care has to be used then choosing gRNA
sequences to minimise the possibilities of off-target. In
the present study, the 2 top off-target regions (Table S1)
were sequenced and showed no editing (FigS3).
Conclusions
The optimised protocol described in this study
allows for relatively fast and cost-effective gene edit-
ing in Chinook salmon cells to generate reporter or
CRISPR KO lines. Cell lines from other salmonid
species such as Atlantic salmon might be readily
transduced with similar lentivirus systems. However,
salmonid cell lines are generally slow growing and
difficult to transfect with plasmids, with the CHSE
being the most amenable to clonal expansion. There-
fore, development of embryonic cell lines from other
salmonid species may be a useful approach to gener-
ate appropriate cell lines for CRISPR KO experi-
ments in other commercially relevant aquaculture
species.
The prospect of developing and applying a genome
wide CRISPR KO screen in fish cell lines is very
attractive for many reasons [6, 10] and the present sys-
tem paves the way towards such a platform for salmo-
nids. This has the potential to be transformative for the
testing of candidate disease resistance genes generated
by Genome-Wide Association Studies as well as de novo
discovery of genes involved in host-pathogen interac-
tions in fish.
Methods
Cell culture
CHSE-214 cell line from Chinook salmon (ECACC
#91041114) was obtained from Sigma (catalogue
#00021714). CHSE-EC were a kind gift from Bertrand
Collet and previously described in [17]. Both salmonid
cell lines were cultured in L15 media (Sigma L1518)
supplemented with 10% heat inactivated fetal bovine
serum (FBS, Gibco) and 1x Pen/Strep (P/S) antibiotics
(Gibco). Cells were cultured at 22 °C (or see optimisation
for other temperatures) without CO2 and split 1:4 at
80% confluency. Lenti-X 293 T (Takara/Clontech, cata-
logue #632180) were cultured in DMEM + 10% FBS,
Penicillin, Streptomycin and Glutamine, Sodium Pyru-
vate and NEAA (all from Gibco). Cells were cultured at
37 °C with 5% CO2 and split 1:20 at 80% confluency.
Puromycin (Cayman chemicals) was used for antibiotic
selection at 0.25 μg/mL for 7 days (Additional file 1:
FigS1). The media was changed every 3–4 days.
gRNA design
All gRNAs were designed using CRISPOR (www.crispor.
tefor.net) and the Chinook salmon reference genome
(NCBI GCF_002872995.1, Otsh_v1.0) was used for off-
target evaluation. The top 2 off-target sites were selected
from the aggregate of MIT and CDF off-target scores
(Supplementary TableS1). The oligos and PCR primers
spanning the edited locus (400–600 bp), synthesised
by IDT or Sigma can be found in Table 1. All oligos
(Table 1) were resuspended to 100 μM in 1x TE.
Plasmids constructs (Table 2)
pKLV2-U6gRNA5(BbsI)-PGKpuro2ABFP-W (pKLV2) was
a gift from Kosuke Yusa (Addgene plasmid # 67974). Spe-
cific gRNA for EGFP and RIG-I (Table 2, underlined) were
cloned according to Golden Gate reaction from ZhangLab
protocol (Addgene SAM library sgRNA cloning protocol)
using BbsI-HF (NEB) and Stbl3 competent E. coli cells
(Thermo Fisher) for transformation. Briefly, 1 μL of each
oligo (100 μM) were mixed with 1 μL of T4 ligation buffer
(NEB) and 7 μL of water. The mix was heated to 95 °C for
5min and cooled to room temperature. 1 μL of the
annealed oligos was mixed with 25 ng of pKLV2, 1 μL of
T4 ligation buffer, 9 μL of water and 0.5 μL of BbsI enzyme
and 0.5 μL of T4 ligase enzyme (200U, NEB). The mix was
incubated for 10 cycles of 5min at 37 °C and 5min at
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23 °C. Five μL were transformed in 50 μL competent E. coli
(Stbl3, Thermo fisher). Four colonies were picked and
grown in LB +Carbenicillin, the plasmids purified (NEB
Monarch Plasmid miniprep) and sequenced to verify
correct insertion using U6_Fw_seq primer (Table 1).
Lentivirus production
Supernatants containing lentiviral particles were pro-
duced by transient transfection of x293T cells using
Lipofectamine 2000 (Invitrogen). To transfect one well
of a 6-well plate, 1.5 × 106 x293T cells were plated in 4
mL of complete media and incubated overnight at 37 °C
(70% confluency at 24 h). The following day, 1.8 μg of
lentiviral vector, 1.8 μg of psPAX2 (gift from Didier
Trono, Addgene plasmid # 12260) and 0.4 μg of
pMD2.G (gift from Didier Trono, Addgene #12259)
were added to 160 μL of Opti-MEM (no phenol red,
Gibco), 12.5 μL of Lipofectamine 2000 was added to
140 μL of Opti-MEM and both tubes incubated for 5
min at room temperature. The Lipofectamine 2000
mixture was then added to the plasmids mixture and
further incubated for 20 min at room temperature. The
transfection complex (300 μL) was added dropwise to
one well of x293T and incubated for 48 h at 37 °C with
CO2. Viral supernatant was then harvested, centrifuged
at 500 x g for 4 min, filtered using a 0.45 μm low pro-
tein retention syringe filter (Sartorius) and 0.5 mL
aliquots were stored at − 80 °C.
Lentiviral transduction
For lentiviral transduction of CHSE or CHSE-EC, 50 μL
of cells (4.105 cells/mL) were mixed with 100 μL of the
lentiviral supernatant (at various dilutions) in a 96-well
plate or 200 μL of cells plus 400 μL of viral supernatant
in 24-well plate, and centrifuged for 2 h at 1000 x g.
Additionally, a lentivirus-free control condition (CHSE-
EC wt) was also included to validate the antibiotic
selection procedure (i.e. 100% death upon puromycin
selection). Media was changed after 4 h or 24 h. After
transduction, cells were incubated at the indicated tem-
peratures and split as needed. Cells were then expanded
once reaching 80% confluence. Antibiotics treatment
was carried out for 7 days and the surviving cells
expanded once reaching 80% confluence. After 2
rounds of expansion, genomic DNA was isolated from
a minimum of 50,000 cells (see 7.7 Sequencing).
Flow cytometry
Transduced cells were detached with trypsin, centrifuged
and resuspended in PBS. The cells were kept on ice and
flow cytometry was performed using a Fortessa-X20 (BD
Biosciences). Events were gated to remove doublet cells
and the GFP intensity of each cell was analysed with
FlowJo 10.6.0 (Becton Dickinson). Transduction effi-
ciency with CMV:EGFP construct (Fig. 1) was calculated
by dividing the number of EGFP positive cells by total
number of cells acquired (minimum 5000 cells).
Table 1 Primers used in the study (from IDT or Sigma). gRNA target sequence underlined
Primers name Primer sequence Annealing temp (°C)
EGFP_Fw_gRNA caccgggcgaggagctgttcaccg N/A
EGFP_Rv_gRNA aaaccggtgaacagctcctcgccc N/A
EGFP_Fw_seq (CMV-F) cgcaaatgggcggtaggcgtg 63.5
EGFP_Rv_seq gctgaagcactgcacgccgt
U6_Fw_Seq (hU6-F) gagggcctatttcccatgatt N/A
Otsha_RIG-I_Fw_gRNA caccgcgttccagaggttgcagag N/A
Otsha_RIG-I_Rv_gRNA aaacctctgcaacctctggaacgc N/A
Otsha_RIG-I_Fw_seq aagtgtcaaagtacagcaattctagc 64
Otsha_RIG-I_Rv_seq cttccagggcatctagcagg
Otsha_RIG-I_OffT1_Fw_seq Offfasasfafqfaf’fI_Off1_Fw_sec tgttgatctctgccttgcac 64
Otsha_RIG-I_OffT1_Rv_seq tatcccaccttggttgcttc
Otsha_RIG-I_OffT2_Fw_sec cggacaacaggccattagat 64
Otsha_RIG-I_OffT2_Rv_sec tggcgtactgcactagcatc
Table 2 Plasmids used in this study (from Addgene, USA)
Plasmid construct Plasmid name (Addgene) Plasmid number (Addgene)
pLenti CMV:EGFP_PGK:Puro pLenti CMV GFP Puro (658–5) 17,448, [43]
pLenti hU6:gRNA_PKG:Puro pKLV2-U6gRNA5(BbsI)-PGKpuro2ABFP-W 67,974, [21]
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Sequencing
Genomic DNA was extracted with QuickExtract
buffer (Lucigen) by adding 30 μL to a single well of a
96-well plate and incubating for 5 min. The samples
were then processed according to the manufacturer’s
instructions (65 °C for 6 min and 98 °C for 2 min).
PCR was performed with 50 μL reactions using NEB
Q5 and 1 μL of the gDNA for 33 cycles amplification
at optimal annealing temperature (see Table 1).
Amplified products were purified using AMPure XP
magnetic beads (Agencourt) according to the manu-
facturer’s instructions. Purified PCR products were se-
quenced by GATC/Eurofins. Sequence (ab1 files) were
analysed with Interference of CRISPR Edits software
(www.ice.synthego.com, [44]) to determine the editing
and knock-out (KO, frame-shift or early stop codon)
efficiency, compared to controls (non-edited).
Cell survival (puromycin resistance)
CellTiter-Glo 2.0 (Invitrogen) was used for cell viabil-
ity assays. Briefly, CHSE-EC cells were plated in 96-
well plate at 8000 cells per well and, after 24 h, differ-
ent concentrations of Puromycin (Cayman chemicals)
were added to each well (in duplicates). After 7 days
incubation at 22 °C, cells were rinsed in PBS and
120 μL of diluted solution of CellTiter-Glo (1:10 in
PBS) was added to each well. The plate was incubated
in the dark for 30 min rocking at room temperature
and 100 μL of the solution was transferred to a flat
bottom white wall 96-well plate (Greiner Bio-One).
The luminescence was measured immediately using a
Cytation 3 imaging reader and the Gen5 software
(V3.03, both from BioTek).
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s12896-020-00626-x.
Additional file 1 Figure S1. Puromycin can be used to select for
resistant cells. CHSE-EC cells were treated for 7 days with different con-
centrations of Puromycin and the survival was calculated by CellTiter-Glo.
A concentration of 0.25 μg/mL of puromycin was found to be the min-
imal concentration to efficiently kill all non-antibiotic-resistant cells.
Additional file 2 Figure S2. Editing efficiency estimation, The analysis
of the editing of pooled cell population samples using ICE online
software. a. The chromatograms (.ab1 file) from the control (non-edited)
and edited samples, along with the gRNA sequence are uploaded on ice.
sythego.com. b. The platform verifies that the cut site corresponds to the
start of the mixed population chromatogram and deconvolutes the picks
to original sequences + or – a few bases. c. The results are presented as
the percentage of each edited sample present in the pooled population
contributing to the mixed chromatogram.
Additional file 3 Figure S3. Off-target editing. Off-target evaluation of
RIG-I editing. a: The sequence of the top 2 off-target sites are represented
along the gRNA sequence used for targeting RIG-I (red box in the mid-
dle). Blue letters indicate differences with the original sequence. An add-
itional nucleotide was sequenced in the CHSE-EC cell line, not present in
the published sequence (Otsh_v1.0, green box). b: Diagram representing
the editing efficiency in the off-target regions (OffT1: ch7:73101728–
73,102,398 and OffT2: ch14:42341999–42,342,859). No off-target was de-
tected by Sanger sequencing in either sample (Puro- and Puro+; all se-
quences, including CHSE-EC (wt) were compared to CHSEwt). c:
Representative chromatogram from the sequencing of off-target region 1
(OffT1) in CHSEwt (Control sample, bottom track) and CHSE-EC-RIG-I Puro
+ (Edited Sample, top track).
Additional file 4 Table S1. Predicted Off-target sites. List of all pre-
dicted off-targets from CRISPOR website for 354 bp in RIG-I exon 2 (Tab1).
The selected gRNA is labeled 224 forw and the list of off-targets can be
found lines 2127–2240. Tab2 summarises the predicted off-targets for
gRNA 224 forw. The sum of the two off-target scores (MIT and CDF) were
calculated to rank the results. The 2 targets selected are highlighted.
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